VAN OORT DOUGLAS M 4
4 · NEOGENOMICS INC · Filed Mar 3, 2020
Insider Transaction Report
Form 4
VAN OORT DOUGLAS M
DirectorChairman and CEO
Transactions
- Tax Payment
Common Stock
2020-03-01−2,353→ 2,281,128 total - Award
Common Stock
2020-03-02+34,945→ 2,316,073 total - Award
Common Stock
2020-03-02$28.33/sh+225,084$6,376,630→ 225,084 totalExercise: $28.33From: 2021-03-02Exp: 2027-03-02→ Common Stock (225,084 underlying)
Holdings
- 500,000
Stock Option (Right to Buy)
Exercise: $8.03From: 2019-02-26Exp: 2023-02-26→ Common Stock (500,000 underlying) - 10,000(indirect: By Children)
Common Stock
- 500,000
Stock Option (Right to Buy)
Exercise: $7.52From: 2018-04-28Exp: 2022-04-28→ Common Stock (500,000 underlying) - 231,567
Stock Option (Right to Buy)
Exercise: $19.60From: 2020-03-01Exp: 2024-03-01→ Common Stock (231,567 underlying)
Footnotes (5)
- [F1]Shares withheld by NeoGenomics Inc. to satisfy the tax obligations in connection with the March 1, 2020 vesting of restricted stock.
- [F2]On April 28, 2017, Mr. VanOort was granted 500,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F3]On February 26, 2018, Mr. VanOort was granted 636,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F4]On March 1, 2019, Mr. VanOort was granted 231,567 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2020, Mr. VanOort was granted 225,084 stock options. These options vest ratably over the first four anniversary dates of the grant date.